Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Cohort Study ◽

Bowel Disease ◽

Observational Cohort ◽

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Yearbook of Medicine ◽

10.1016/s0084-3873(10)79832-1 ◽

2010 ◽

Vol 2010 ◽

pp. 452-453

Author(s):

M.F. Picco

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Observational Cohort ◽

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Yearbook of Pediatrics ◽

10.1016/s0084-3954(10)79709-8 ◽

2011 ◽

Vol 2011 ◽

pp. 174-176

Author(s):

J.A. Stockman

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Observational Cohort ◽

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

The Lancet ◽

10.1016/s0140-6736(09)61302-7 ◽

2009 ◽

Vol 374 (9701) ◽

pp. 1617-1625 ◽

Cited By ~ 650

Author(s):

Laurent Beaugerie ◽

Nicole Brousse ◽

Anne Marie Bouvier ◽

Jean Frédéric Colombel ◽

Marc Lémann ◽

...

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Observational Cohort ◽

Su1333 Influence of Coping Strategies on the Clinical Course of Inflammatory Bowel Disease: A Prospective, Observational Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(14)61577-8 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-439

Author(s):

Rocio Ferreiro ◽

Manuel Barreiro-de Acosta ◽

Aurelio Lorenzo ◽

Enrique Dominguez-Munoz

Keyword(s):

Cohort Study ◽

Coping Strategies ◽

Bowel Disease ◽

Clinical Course ◽

Observational Cohort ◽

Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw087 ◽

2016 ◽

Vol 10 (11) ◽

pp. 1287-1293 ◽

Cited By ~ 95

Author(s):

Lisa J. T. Smits ◽

Lauranne A. A. P. Derikx ◽

Dirk J. de Jong ◽

Ronald S. Boshuizen ◽

Aura A. J. van Esch ◽

...

Keyword(s):

Cohort Study ◽

Clinical Outcomes ◽

Bowel Disease ◽

Observational Cohort ◽

P528 Patients’ perspectives on switching from reference infliximab to CT-P13 biosimilar in patients with inflammatory bowel disease: A 12-month prospective observational cohort study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.655 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S373-S374 ◽

Cited By ~ 1

Author(s):

N Petitdidier ◽

C Gagniere ◽

A L Rentien ◽

J Tannoury ◽

Y Le Baleur ◽

...

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Observational Cohort ◽

Switching From Remicadeâ® to Biosimilar ct-P13 in Inflammatory Bowel Disease Patients: One Year Follow-Up of a Prospective Observational Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(17)32110-8 ◽

2017 ◽

Vol 152 (5) ◽

pp. S587

Author(s):

Lisa Smits ◽

Anna Grelack ◽

Joost Drenth ◽

Dirk J. De Jong ◽

Ronald Boshuizen ◽

...

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Observational Cohort ◽

Inflammatory Bowel ◽

One Year

P490 Drug survival and immunogenicity after switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: Two-year follow-up of a prospective observational cohort study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.617 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S353-S353

Author(s):

L Smits ◽

L Derikx ◽

A van Esch ◽

J Drenth ◽

R Boshuizen ◽

...

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Drug Survival ◽

Observational Cohort ◽

Mo1844 - Drug Survival and Immunogenicity after Switching from Remicade ® to Biosimilar Ct-P13 in Inflammatory Bowel Disease Patients: Two Year Follow-Up of a Prospective Observational Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(18)32808-7 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-822

Author(s):

Lisa Smits ◽

Lauranne Derikx ◽

Aura van Esch ◽

Joost Drenth ◽

Ronald Boshuizen ◽

...

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Drug Survival ◽

Observational Cohort ◽

Mo1913 – Two Year Experience with Vedolizumab in Inflammatory Bowel Disease Patients: Results of the Icc Case Series, a Nationwide Prospective Observational Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(19)39180-2 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-884

Author(s):

Vince Biemans ◽

Christien Janneke Van Der Woude ◽

Gerard Dijkstra ◽

Andrea v. Meulen de Jong ◽

Bas Oldenburg ◽

...

Keyword(s):

Cohort Study ◽

Bowel Disease ◽

Case Series ◽

Observational Cohort ◽